Ipamorelin
Ipamorelin Original price was: $70.00.Current price is: $49.00.
Back to products
GLP-2 TZ
GLP-2 TZ Original price was: $100.00.Current price is: $65.00.

GLP-3 R

Original price was: $111.50.Current price is: $78.00.

Buy high-purity GLP-3 R 10mg research peptides. Third-party lab tested: >99% purity and ultra-low (<0.25 EU) endotoxins.

GLP-3 R 10mg Technical Specifications

  • Verified Purity (HPLC): 99.67%

  • Actual Peptide Content: 12.16mg (Overfilled for guaranteed yield)

  • Endotoxin Levels: None Detected (Ultra-low, <0.25 EU threshold)

  • Testing Date: April 15, 2026

Description

Product details

Amino Acid Sequence

Tyr-{Aib}-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{α-Me-Leu}-Leu-Asp-Lys-{diacid-C20-γ-Glu-(AEEA)-Lys}-Ala-Gln-{Aib}-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH₂

Molecular Formula

C₂₂₁H₃₄₂N₄₆O₆₈

Molecular Weight

4 731.33 g/mol

PubChem CID

485 663 353

CAS Number

2381089-83-2

Vial Size

3ml

Contents

Lyophilized powder, white/off-white color

Mechanism of action

Triple GIP/GLP-1/GCGR Receptor Agonism & Insulinotropic Effect

GLP-3 R simultaneously engages GIP, GLP-1, and glucagon receptors on pancreatic β-cells, amplifying cAMP signaling to enhance glucose-dependent insulin secretion and suppress glucagon release.

Delayed Gastric Emptying & Reduced Gastrointestinal Motility

Activation of GLP-1 receptors in the gut and on vagal afferents slows gastric emptying and intestinal transit, reducing postprandial glucose excursions and contributing to satiety.

Central & Peripheral Appetite Suppression

In preclinical models, retatrutide crosses the blood–brain barrier to engage hypothalamic pathways that reduce caloric intake, while glucagon receptor activation increases energy expenditure—together driving significant weight reduction .

Storage & handling

Storage:

Store the lyophilized vial in a cool, dry area protected from direct sunlight.
Legal Disclaimer

All products on this site are for research and development, laboratory, or analytical use only; they are not for human consumption, medical, diagnostic, cosmetic, veterinary, or any other non-research application. The statements and products have not been evaluated by the U.S. Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. Honest Peptide is not a compounding pharmacy or chemical compounding facility as defined under section 503A of the Federal Food, Drug, and Cosmetic Act, nor an outsourcing facility as defined under section 503B.